Torts

Massive Spike in Fraudulent Claims Shadows Rise of Digital Payouts in Class Actions and Mass Torts, Report Reveals

by

Phoenix, AZ – The dramatic surge in fraudulent claims across class actions and mass torts has highlighted the escalating need for enhanced scrutiny and the potential for digital payment solutions to mediate concerns, suggest findings from a recent report by Western Alliance Bank and Digital Disbursements. The study, analyzing over 597 payouts from 2019 to 2023, reveals a 400% jump in fraud-indicative claims last year alone, totaling 80 million instances, compared to under two million in the preceding year. Jeff Richardson, co-founder and CEO of Digital Disbursements, commented on the trend, noting that this surge … Read more

Diving Deep into Justice Thomas’s Dissent: The Impact on Mass Torts and Multidistrict Litigation

by

Washington, D.C. – The world of mass torts and multidistrict litigation often operates quietly behind the more sensational headlines, yet it significantly impacts American jurisprudence and the lives of countless individuals. These mechanisms are designed to manage large-scale litigation efficiently, where many individuals allege similar harms caused by the same source. Recently, the principles upending these legal procedures were highlighted in Justice Clarence Thomas’s dissent in a particular Supreme Court decision, casting a significant spotlight on the ongoing debate regarding the use of collateral estoppel in multidistrict litigation. Justice Thomas’s dissent critically examined the notion … Read more

Zantac Ruling in Delaware Could Transform State into Mass Torts Hub

by

Wilmington, DE — A recent ruling by a Delaware judge denying the consolidation of approximately 140 lawsuits against the manufacturers of Zantac could position the state as a new focal point for mass tort litigation. The decision by the Superior Court in Wilmington diverges notably from trends in other states where large-scale pharmaceutical lawsuits have been consolidated. The plaintiffs in these cases allege that Zantac, a popular over-the-counter heartburn medication, caused a variety of cancers. The claims have been spurred by studies indicating that the drug could turn into a carcinogenic substance under certain conditions. … Read more

King & Spalding Recognized as Finalist in Litigation Departments of the Year for Excellence in Products Liability and Mass Torts

by

New York, NY – King & Spalding, a leading law firm known for handling significant product liability and mass tort cases, has been recognized as a finalist in the Litigation Department of the Year awards. Kristen Fournier, a partner at the firm, responded to queries about the department’s formidable achievements over the past year, attributing their successful track record to their comprehensive approach to crises and complex legal challenges faced by their clients. The firm boasts a robust method that is both proactive and responsive, ideally positioned for clients who find themselves on the brink … Read more